TNF Pharmaceuticals, Inc. SC 13D and SC 13D/A reports

Location
855 N. Wolfe Street, Suite 601, Baltimore, MD
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
8/19/2024, 06:32 AM
Form type Sec Links Description Filing date Reporting date
SC 13D Report SCHEDULE 13D May 30, 2024
SC 13D Report Sep 8, 2022
SC 13D Report Apr 27, 2021
SC 13D Report SC 13D Feb 18, 2014